Discover Insmed's innovative therapies targeting rare diseases, with approvals like Brinsupri boosting potential.

Tax-free interest on eligible NRE accounts: The Bank allows NRIs to earn interest without paying tax in India, subject to applicable regulations. Assistance with tax forms and compliance: IDFC FIRST ...

The FDA has approved Insmed’s Brinsupri™ (brensocatib 10 mg and 25 mg tablets) as the first drug authorized to treat ...